05 | Allele matcher scoring scheme alterations | TopicSem |
11 | Problems with allele matcher switching from VCF to GVCF | MAInfo | ||
22 | Allele matcher fine-tuning and scoring scheme alterations | TopicSem |
09 | Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension | J.Club | ||
18 | NamedAlleleMatcher101 replication | TopicSem |
15 | Identifying Splicing Synthetic Cancer Survival in Lung Adenocarcinoma using pooled isoform-based method | TopicSem | ||
22 | Significantly regulated multi-isoform genes | MAInfo | ||
23 | PharmCAT review | SysBiol |
18 | Identifying Splicing Synthetic Cancer Survival in Lung Adenocarcinoma using isoform-based method | TopicSem | ||
26 | Extracting information from PharmGKB | SysBiol |
14 | Identification of Synthetic Splicing Cancer Survival in Lung Adenocarcinoma | TopicSem |
10 | Chemotherapy and adverse drug reactions in Acute Myeloid Leukemia | SysBiol | ||
29 | Disease variants alter transcription factor levels and methylation of their binding sites | J.Club |
12 | Roles of Solute Carriers and the functional consequences of polymorphism | SysBiol | ||
14 | Calculating ERK score of THCA samples | MAInfo | ||
28 | Preliminary miRNA analysis on THCA samples | TopicSem |
05 | Isoform fraction analysis methodology | MAInfo | ||
17 | Isoform fraction analysis in THCA | TopicSem |
08 | Converting GDC UUID to TCGA barcode | MAInfo | ||
23 | Effects of variants in transporter genes on drug efficacy and toxicity | SysBiol |
18 | Identification of alternative splicing event pairs and their effects on survival using pairwise survival analysis | TopicSem |
07 | Survival analysis of mNA isoform variation using TCGA datai | TopicSem | ||
14 | DMET data processing protocol | SysBiol |
03 | SFINX database | SysBiol | ||
19 | Taking rMATS output files and plotting aligned exon read densities using Sashimi plot | MAInfo |
21 | Methods for assessing effects of variants on alternative splicing and disease | TopicSem |
16 | Identification of important lncRNAs and highly recurrent aberrant alternative splicing events in HCC through integrative analysis of multiple RNA Seq datasets | J.Club |
18 | BRAF/RAS intron retention comparison using MISO | TopicSem | ||
23 | Intron retention is a widespread mechanism of tumor-suppressor inactivation | J.Club |
09 | Testing PharmPortal drug sets for validity | TopicSem | ||
21 | DrugBank XML structures and parsing | SysBiol | ||
21 | DrugBank XML structures and parsing | SysBiol | ||
25 | MISO pilot results | MAInfo |
11 | MISO review | MAInfo | ||
13 | Identifying adverse drug reactions and drug-induced diseases using network-based drug mapping | J.Club |
05 | PharmPortal Updated Database Schema | SysBiol | ||
20 | Updated Database and Fine-tuning plans | TopicSem | ||
26 | PharmSafe Report calculations | SysBiol |
21 | PharmPortal Updates | TopicSem | ||
22 | Fine-tuning plans | SysBiol |
18 | PharmPortal update | TopicSem | ||
28 | DGIdb 2.0: mining clinically relevant drug-gene interactions | J.Club |
12 | Summary Page Development for PharmPortal | TopicSem |
05 | Achieving high-sensitivity for clinical applications using augmented exome sequencing | J.Club | ||
14 | PharmPortal: Core Function Development on the Web | TopicSem |
04 | Core functions of PharmPortal | SysBiol |
22 | PharmPortal: Request Processing Flow | TopicSem |
15 | PharmPortal: Updated Web design | TopicSem | ||
20 | DSigDB: Drug Signatures Database for Gene Set Analysis | J.Club |
18 | PharmPortal: Data integration and Web Design | TopicSem |
04 | SFINX - a drug-drug interaction database designed for clinical decision support systems | J.Club | ||
13 | PharmPortal: ADR information extraction & integration | TopicSem |
11 | PharmPortal: Drug Information database parsing | TopicSem |
17 | In silico comparative characterization of pharmacogenomic missense variants | J.Club | ||
26 | Pharmportal: pharmacogenomic database integration | TopicSem | ||
26 | SG09 | Seminar |
10 | Imputation of KARE data | TopicSem |
01 | Identifying the effect of a variant within transporter to drug efficacy | TopicSem |
18 | Drug Transporters in Drug Efficacy and Toxicity Review | SysBiol | ||
18 | Drug Transporters in Drug Efficacy and Toxicity Review | SysBiol | ||
18 | Drug Transporters in Drug Efficacy and Toxicity Review | SysBiol |
12 | Therapeutic Targets Database review | SysBiol |
02 | An analysis protocol for Ion Proton sequencing data at low level | xMutant |